Profile data is unavailable for this security.
About the company
Kadimastem Ltd is an Israel-based regenerative medicine company focused on the industrial development and commercialization of stem cell-based therapeutics, primarily for diabetes and neurodegenerative disorders. The Company’s technology enables the differentiation of stem cells into insulin secreting beta cells, as well as a range of neural cells (including Oligodendrocytes, Astrocytes). The Company produces islet-like clusters that show glucose-stimulated insulin secretion. In addition, the Company is partnering with pharmaceutical companies interested to screen potential drug compounds (hit-lead, lead optimization) on its stem-cell derived cells, primarily oligodendrocytes and astrocytes.
- Revenue in ILS (TTM)0.00
- Net income in ILS-12.01m
- Incorporated2008
- Employees32.00
- LocationKadimastem Ltd.Pinchas Sapir 7, Weizmann Science ParkNESS-ZIONA 74140IsraelISR
- Phone+972 89100695
- Fax+972 89100698
- Websitehttps://www.kadimastem.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HBL Hadasit Bio Holdings Ltd | 0.00 | -29.19m | 5.89m | 16.00 | -- | 0.9918 | -- | -- | -2.63 | -2.63 | 0.00 | 0.5354 | 0.00 | -- | -- | -- | -124.15 | -13.00 | -137.60 | -13.91 | -- | -- | -- | -100,517.40 | -- | -0.065 | 0.2098 | -- | -- | -- | 6.48 | -- | -- | -- |
| Flying Spark Ltd | 16.00k | -11.47m | 8.25m | -- | -- | -- | -- | 515.88 | -1.84 | -1.84 | 0.0022 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -218.75 | -- | -71,731.25 | -- | -- | -41.04 | -- | -- | 71.43 | -- | -248.13 | -- | -- | -- |
| Plantarc Bio Ltd | 4.78m | -2.11m | 9.12m | -- | -- | 0.7626 | -- | 1.91 | -0.6359 | -0.6359 | 1.44 | 3.61 | 0.3363 | -- | 13.48 | -- | -14.84 | -37.73 | -16.44 | -41.77 | 61.43 | -- | -44.12 | -376.62 | -- | -- | 0.0059 | -- | -- | -- | 57.69 | -- | 111.75 | -- |
| Millennium Food-Tech LP | 464.00k | -25.91m | 18.44m | 2.00 | -- | 0.164 | -- | 39.75 | -0.9204 | -0.9204 | 0.018 | 3.44 | 0.0038 | -- | 3.40 | 232,000.00 | -21.38 | -- | -21.52 | -- | -- | -- | -5,584.27 | -- | -- | -0.17 | 0.00 | -- | 224.48 | -- | -84.01 | -- | -- | -- |
| Kadimastem Ltd | 0.00 | -12.01m | 21.51m | 32.00 | -- | -- | -- | -- | -1.22 | -1.22 | 0.00 | -1.04 | 0.00 | -- | -- | -- | -115.17 | -155.33 | -1,153.60 | -1,831.12 | -- | -- | -- | -- | -- | -9.44 | 3.22 | -- | -- | -- | 47.14 | -- | -50.73 | -- |
| Nextage Therapeutics Ltd | 876.00k | -4.07m | 28.62m | -- | -- | -- | -- | 32.68 | -0.1396 | -0.1396 | 0.03 | -0.0958 | 0.672 | -- | 6.82 | -- | -322.44 | -188.94 | -- | -423.76 | 25.68 | 33.33 | -479.79 | -2,486.19 | -- | -18.46 | -- | -- | -- | 17.99 | 27.21 | -- | -- | -- |
| Cannassure Therapeutics Ltd | 11.00m | -1.18m | 31.03m | -- | -- | -- | 111.61 | 2.82 | -1.43 | -2.16 | 13.28 | -3.66 | 0.5329 | 1.37 | 4.47 | -- | -5.74 | -45.39 | -18.34 | -92.41 | 29.17 | -- | -10.77 | -83.49 | 0.0474 | 0.9011 | -- | -- | -67.44 | -- | 78.37 | -- | -72.23 | -- |
| Tikun Olam Cannbit Pharmaceuticals Ltd | 44.23m | -88.89m | 33.73m | 51.00 | -- | 0.786 | -- | 0.7627 | -1.43 | -1.43 | 0.7018 | 0.5051 | 0.379 | 2.87 | 19.85 | 867,215.70 | -80.56 | -30.17 | -99.81 | -35.04 | -0.4273 | -- | -212.57 | -146.42 | 0.5033 | -30.02 | 0.3778 | -- | -10.28 | -- | -84.28 | -- | -8.71 | -- |
| Can Fite Biopharma Ltd | 2.79m | -28.64m | 39.17m | 5.00 | -- | 1.52 | -- | 14.06 | -0.0228 | -0.0228 | 0.0022 | 0.0172 | 0.0771 | -- | -- | 557,428.30 | -79.22 | -102.29 | -103.51 | -131.07 | -- | -- | -1,027.46 | -1,105.36 | -- | -- | 0.00 | -- | -8.27 | -27.92 | 24.96 | -- | -42.92 | -- |
| Grace Breeding Ltd | 463.00k | -8.50m | 44.02m | -- | -- | 27.77 | -- | 95.08 | -2.36 | -2.25 | 0.1296 | 0.3998 | 0.0848 | 2.73 | 0.9636 | -- | -164.09 | -- | -206.24 | -- | 80.56 | -- | -1,935.21 | -- | 1.45 | -94.74 | 0.5103 | -- | 121.53 | -- | 23.10 | -- | -- | -- |
| Wilk Technologies Ltd | 0.00 | -10.93m | 47.21m | 4.00 | -- | 6.83 | -- | -- | -0.1807 | -0.1807 | 0.00 | 0.1006 | 0.00 | -- | -- | -- | -80.10 | -266.55 | -96.15 | -298.65 | -- | -- | -- | -97,340.88 | -- | -39.62 | 0.4049 | -- | -- | -- | 36.02 | -- | -- | -- |
| X T L Biopharmaceuticals Ltd | 1.70m | -84.36m | 53.19m | 33.00 | -- | 0.6308 | -- | 31.23 | -0.3831 | -0.3831 | 0.0077 | 0.1548 | 0.0192 | -- | 0.7012 | 51,607.42 | -94.96 | -53.17 | -111.98 | -59.10 | -- | -2.33 | -4,953.75 | -1,084.42 | -- | -- | 0.00 | -- | -85.80 | -- | -7.97 | -- | -53.12 | -- |
| Purple Biotech Ltd | 0.00 | -74.57m | 58.33m | 20.00 | -- | 0.4414 | -- | -- | -0.3178 | -0.3178 | 0.00 | 0.5084 | 0.00 | -- | -- | 0.00 | -40.39 | -37.24 | -47.34 | -41.28 | -- | -- | -- | -9,415.70 | -- | -- | 0.0101 | -- | -- | -- | 8.25 | -- | -28.45 | -- |
Data as of May 02 2024. Currency figures normalised to Kadimastem Ltd.'s reporting currency: Israeli Shekel ILS
0.11%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Altshuler Shaham Mutual Funds Management Ltd.as of 31 Jan 2024 | 4.71k | 0.11% |
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
